In the BioHarmony Drug Report Database

"Preview" Icon

Vinorelbine

Navelbine (vinorelbine) is a small molecule pharmaceutical. Vinorelbine was first approved as Navelbine on 1994-12-23. It is used to treat breast neoplasms, hodgkin disease, non-small-cell lung carcinoma, and ovarian neoplasms in the USA.

 

Trade Name

 

Navelbine
 

Common Name

 

vinorelbine
 

ChEMBL ID

 

CHEMBL553025
 

Indication

 

breast neoplasms, hodgkin disease, non-small-cell lung carcinoma, ovarian neoplasms
 

Drug Class

 

Vinca alkaloids

Image (chem structure or protein)

Vinorelbine structure rendering